Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 63 EP83 | DOI: 10.1530/endoabs.63.EP83

Gynecology, Monastir, Tunisia.


Introduction: Hyperprolactinemia may be physiological or caused by discontinuation of normal prolactin regulation because of certain drugs or by other diseases such as kidney, ovarian and thyroid diseases.

Materials and methods: This is a retrospective study of 30 patients presenting with hyperprolactinemia.

Results: The average age was 30 years old. 20 patients married, 10 no married (30%). The indication of the prolactin dosage was primary or secondary amenorrhea in 5 cases (16.5), isolated galactorrhoea in 8 cases (26%) or associated in 9 cases (30%), cycle disorders in 18 cases or primary or secondary sterility in 5 cases. The clinical examination was normal in 10 cases and abnormal in 16 CAS. The etiological investigation of hyperprolactinemia was based on MRI in 16 cases (53%), 11 of which were pathological, one in 10 cases (37%), 2 of which were pathological, one sella turcica in 4 cases (13%), 8%), mammary cytology in 2 cases and mammography in 8 cases. The driving was based on medical treatment, other treatment in 8 cases; discontinuation of drug intake in 3 patients; a patient was referred to neurosurgery.

Conclusion: Prolactinemia remains an essential biological examination for diagnostic orientation in certain pathologies. MRI is now the only way to confirm the diagnosis of pituitary adenomas.

Volume 63

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

Hyperprolactinemia (<1 min ago)